Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
about
Human apoB contributes to increased serum total apo(a) level in LPA transgenic miceTransgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural geneComplete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1A novel functional role for apolipoprotein B in male infertility in heterozygous apolipoprotein B knockout miceLoss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptorsMapping the mouse genome: current status and future prospects.Characterization of a plant-transformation-ready large-insert BIBAC library of Arabidopsis and bombardment transformation of a large-insert BIBAC of the library into tobacco.Lipoprotein(a) accelerates atherosclerosis in uremic mice.Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis.Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic miceGenerating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes.Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental systemRhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoformsApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation.Beyond genome-wide association studies: the usefulness of mouse genetics in understanding the complex etiology of atherosclerosis.Lipoprotein(a): biology and clinical importanceAtherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.Single base, site-directed mutagenesis of a 90 kilobase-pair P1 cloneHuman apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunctionLow density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.Biological insights through genomics: mouse to man.Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.Apo B100-containing lipoproteins are secreted by the heartLp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.Lipoprotein(a): resurrected by genetics.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.Structural requirements of apo-a for the lipoprotein-a assembly.Atherosclerosis and the mouse: a decade of experience.Message therapy: gene therapy that targets mRNA sequence and stability.Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants.Apolipoprotein B gene expression in a series of human apolipoprotein B transgenic mice generated with recA-assisted restriction endonuclease cleavage-modified bacterial artificial chromosomes. An intestine-specific enhancer element is located betwee
P2860
Q24796498-D6067393-341D-44BB-A328-AF784CC5DF6DQ28281569-CDB964D5-A726-449A-8579-EC76F81C58B2Q28291031-FC416062-944C-4C95-8C5F-9D679014AC0EQ28508453-CDC6CF2F-6A7B-429B-B366-E08D1E92229CQ28508701-A0FAB20D-57F0-4BA7-985E-8CC87665259BQ33738135-DBAD9F69-6901-4AB7-850F-58C3C78842E1Q33902635-1B9ED31B-E8BA-4363-B2C3-B1066F18EB83Q34116300-045E048D-52EB-418B-A4F4-4DADCDFF75E3Q34140556-7703075A-6442-478D-AC21-A022B5379993Q34430592-B17A3BA4-56F4-411F-8D5F-7612DA415C82Q34468652-766D9AD1-93B5-49BA-A9AF-3842AF8DFBE2Q34531240-485BC0F3-0D5C-442B-A320-070AD6B055CEQ35602654-F7F3BB78-A711-42B3-8590-EC7B2D189B10Q35693962-18FFDCA9-D030-4AB1-BADF-B3B78D36A967Q35739449-B062C492-43B4-410B-8283-DDF5553B2264Q35754367-1C5B3DD4-5D36-433F-9B89-AFC7D4265BECQ35763619-3EA9D170-8B4C-4C46-AE64-6073F814912DQ35824543-AE049AC0-025F-407F-8993-DD0304C5F7EDQ35857659-6C6040B8-F0AB-444C-946E-2937B3D4BD88Q35871092-412A9A5D-8C65-45F6-893A-8D49205BDCF5Q35992007-97061DB4-D98F-45EA-9ABD-1F369B19A564Q36476141-8B8E3785-6C48-4FD2-94BA-6C85768F735DQ36736883-EA430F80-6564-4507-BF16-C934F103CD44Q37311007-AEB79082-571C-4290-8B5F-68CA2DF54839Q37350057-C319A39E-E1DE-410B-9DFD-4E05A221F05CQ37370315-E038E482-276C-43FE-8911-B00F771F4FCEQ37372596-4D954207-EED8-4A1A-8AD4-1A124BA70D7FQ37379121-4ED1B85E-0118-4B57-BED6-036AAFC4CDA5Q37734908-0CA3FF47-34CF-4560-A10A-9DD9213E9DE2Q38045424-23C58AAD-5102-434C-8E60-B0B9F7CB9883Q38243345-A2AF580C-D636-429B-85EB-34BDBC30FC0EQ38290401-9D822518-BBAF-443B-8FAC-CCA926A094A0Q41428710-49401DC1-3C14-4E1B-97B2-23FAA879073BQ41548189-A749F268-8993-4D99-974D-79AA6F276CDCQ41650542-C7A64760-8ACA-47A9-B627-4D5700C4844BQ43764702-A7AA3026-4344-4319-9DDA-DC2F3432E68FQ44053804-488B08D4-8469-41DF-89DE-765621AD49C5Q44666420-25F2FB32-29CF-4EAD-A6B5-7FA3CAA95760Q45285259-04CF39D1-B7BD-4AC3-AF6D-64BFD35449A9Q46230325-A7AE47DE-406C-47B4-B6A0-15E0196C8426
P2860
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@ast
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@en
type
label
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@ast
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@en
prefLabel
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@ast
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@en
P2093
P2860
P356
P1476
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.
@en
P2093
L J Stoltzfus
M J Callow
P2860
P304
P356
10.1073/PNAS.91.6.2130
P407
P577
1994-03-01T00:00:00Z